Tang Capital Management’s Calliditas Therapeutics CALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-100,000
Closed -$2.48M – 57
2021
Q4
$2.48M Buy
+100,000
New +$2.01M 0.5% 25

Other funds holding CALT

Tang Capital Management's CALT Position: Q1 2022 in Review

Tang Capital Management sold out of Calliditas Therapeutics (CALT) in Q1 2022, closing a stake of 100,000 shares — an estimated $2.48M sold.

Tang Capital Management first reported a position in CALT in Q4 2021 and held it in 1 quarter. The position peaked at $2.48M in Q4 2021. 17 funds tracked by Wall St. Rank hold CALT as of Q1 2022.

  • Tang Capital Management reported no remaining Calliditas Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Tang Capital Management sold 100,000 Calliditas Therapeutics shares in Q1 2022, an estimated $2.48M.
  • Tang Capital Management first reported a position in Calliditas Therapeutics in Q4 2021 and held it in 1 quarter.
  • Tang Capital Management's Calliditas Therapeutics position peaked at $2.48M in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Calliditas Therapeutics as of Q1 2022.

Based on Tang Capital Management's 13F filing for Q1 2022, filed 16 May 2022.